About Ultrasight
UltraSight is a pioneering healthcare AI company focused on transforming cardiac ultrasound through advanced machine learning. Their core product, the UltraSight Echosystem, is an AI-driven software that provides real-time guidance and quality assessment, enabling medical professionals—even those without extensive sonography experience—to acquire timely and accurate cardiac ultrasound images. This technology aims to make diagnostic imaging more accessible across various care settings, including clinics, community hospitals, emergency departments, intensive care units, and remote locations.
The company’s mission is to expand access to high-quality cardiac care by simplifying the process of cardiac sonography. The UltraSight Echosystem combines structured training, real-time AI guidance, and advanced analytics to facilitate focused echocardiography examinations under qualified physician oversight. This approach helps health systems address workforce constraints, improve cardiac workflows, and expedite care for patients, ultimately leading to quicker diagnoses and improved patient outcomes. UltraSight’s software has received FDA 510(k) clearance, UKCA, CE Mark, and Israeli AMAR clearance.
Focus Areas
Business Intelligence
| Technology | Deep learning-based Real-Time Guidance software, AI-driven software for real-time guidance and quality assessment, geometrical deep learning AI. Integrates with healthcare IT standards such as PACS, FHIR, EMR/EHR, and DICOM. |
What Physicians Need to Know
For physicians, UltraSight's technology offers a significant advantage by enabling a wider range of healthcare professionals, including non-sonographers, to perform diagnostic-quality cardiac ultrasounds at the point of care. This can lead to faster cardiac insights, reduced backlogs in echo labs, and more timely clinical decision-making, especially in critical care, emergency, and inpatient settings. The AI-guided system helps ensure consistent image quality and provides automated quality assurance, reducing variability and supporting reliable, repeatable focused cardiac ultrasounds (FoCUS). This allows specialized sonographers and cardiologists to focus on more complex cases, optimizing resource allocation and improving overall patient flow and outcomes. Clinical studies have shown that novice operators using UltraSight's AI guidance can achieve diagnostic-quality images with high accuracy and proficiency after a minimal number of scans, significantly accelerating skill acquisition compared to traditional training methods.
UltraSight's AI guidance software is designed for easy integration with compatible general-purpose diagnostic ultrasound systems, including handheld, laptop, and cart-based systems. They have specifically partnered with companies like Butterfly Network and EchoNous to integrate their real-time AI guidance software with their portable ultrasound devices, and also integrate with Philips Lumify. This multi-device compatibility allows health systems to deploy UltraSight technology across their existing ultrasound infrastructure without requiring hardware replacement, facilitating broader adoption and scalability within various clinical workflows.
What the Web Says
Ultrasight is a digital health company that uses AI to guide medical professionals in performing cardiac ultrasound examinations, even those without prior sonography experience. The company's AI guidance system has received CE Mark approval in Europe and FDA clearance in the U.S., allowing for wider adoption in clinical settings. Studies have shown that novice users can acquire diagnostic-quality cardiac ultrasound images with high accuracy after minimal training using Ultrasight's technology. The company recently raised $24 million to expand its U.S. commercialization efforts.
Overall: PositiveStrengths
- Enables medical professionals without prior sonography experience to perform diagnostic-quality cardiac ultrasounds.
- Reduces the learning curve and training time for echocardiograms.
- Increases access to cardiac imaging and can reduce wait times.
- Provides real-time AI guidance and quality assessment for accurate image acquisition.
- Compatible with existing point-of-care ultrasound systems like Philips Lumify.
- Potential to improve diagnostic efficiency and patient satisfaction.
Limitations
- Limited information available on employer reviews on major platforms like Glassdoor.
- No user reviews found on G2 or Capterra specifically for "Ultrasight" (cardiac imaging AI).
- Some search results for "Ultrasight" on Reddit and other platforms refer to different products (e.g., robot vacuums, website builders), making it difficult to filter relevant feedback.
- The software was recently under FDA review, indicating it's a relatively new product in the US market.
Based on reviews from: ultrasight.com, prnewswire.com, dicardiology.com, firstsales.io, capterra.com, trustpilot.com, g2.com, proquest.com, auntminnie.com, advamed.org, reddit.com, indeed.com
Last updated: 2026-10-28
Videos
News, demos, and interviews about Ultrasight.
Videos load interactively. If none appear, search YouTube for Ultrasight →
Press & Coverage
Frequently Asked Questions
Related Companies
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]
Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]
Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]
CortiCare is a healthcare AI company specializing in neuro telemetry and remote patient monitoring, primarily focusing on electroencephalogram (EEG) services. The company provides telehealth services and an EEG brain monitoring platform to neurology and critical care areas within hospitals, including ICUs, NICUs, PICUs, and EMUs. Their services aim to enhance the neurological assessment of adult, […]
CapsoVision is a commercial-stage medical technology company that develops advanced imaging and artificial intelligence (AI) technologies for capsule endoscopy solutions. Their primary goal is to identify abnormalities of the gastrointestinal (GI) tract for diagnostic and screening purposes. [7] Their flagship product, the CapsoCam Plus system, is a single-use capsule endoscope equipped with four cameras, providing […]